Maladaptive memories that associate environmental stimuli with the effects of drugs of abuse are known to be a major cause of relapse to, and persistence of, a drug addictive habit. However, memories may be disrupted after their acquisition and consolidation by impairing their reconsolidation. Here, we show that infusion of Zif268 antisense oligodeoxynucleotides into the basolateral amygdala, prior to the reactivation of a well-learned memory for a conditioned stimulus (CS)-cocaine association, abolishes the acquired conditioned reinforcing properties of the drug-associated stimulus and thus its impact on the learning of a new cocaine-seeking response. Furthermore, we show that reconsolidation of CS-fear memories also requires Zif268 in the amygdala. These results demonstrate that appetitive CS-drug memories undergo reconsolidation in a manner similar to aversive memories and that this amygdala-dependent reconsolidation can be disrupted to reduce the impact of drug cues on drug seeking.
. Indeed, a specific test of the conditioned reinforcing properties of a CS is its ability to support new instrumental learning (Mackintosh, 1974) , and so an acquisition of new response with conditioned reinforcement procedure can be used to assess the impact that drug cues will have on drug seeking. Indeed, this procedure models directly one important aspect of human addictive behavior, namely the rapid acquisition of novel, flexible drug-seeking strategies (Di Ciano and Everitt, 2004) .
Therapeutically, there is great interest in reducing the impact that drug cues have on addictive behavior and relapse, and to prevent them from reinforcing new drug-seeking actions that lead to the compulsive drugseeking characteristic of the addicted state (DSM-IV-TR, 2000). Though extinction of the CS-drug association has not proved to be effective in reducing drug seeking or relapse in either humans (Conklin and Tiffany, 2002) or rats (Di Ciano and Everitt, 2004), the behavioral impact of a CS may be greatly reduced by preventing the reconsolidation of the previously learned memories that are retrieved and reactivated by its presentation (Nader et al., 2000) . Reconsolidation impairments, characterized by amnesia that is critically dependent upon memory reactivation through CS exposure, have been observed in several forms of memory (Alberini, 2005; Dudai and Eisenberg, 2004). Importantly, reconsolidation of amygdala-dependent conditioned fear has been disrupted by intraamygdala infusion of the protein synthesis inhibitor anisomycin (Nader et al., 2000) . The basolateral amygdala (BLA) is an important locus of CS-US associations in both aversive and appetitive learning (Everitt et al., 2000; LeDoux, 2000) , and BLA lesions impair the ability of drug-associated CSs to acquire drug seeking under a second-order schedule of reinforcement (Whitelaw et al., 1996) , and to induce reinstatement of drug seeking following extinction in rats (Meil and See, 1997) . The hypothesis that we tested here was that drug memories undergo BLAdependent reconsolidation and that preventing this process would reduce the impact that drug cues have on drug seeking and relapse.
A protein that may be necessary for the reconsolidation of amygdala-dependent CS-US associations is the product of the immediate-early gene Zif268 (also known as EGR1, NGFI-A, and Krox24), since its expression is significantly upregulated in the BLA following reexposure to discrete CSs previously associated with either footshock (Hall et al., 2001 ) or self-administered cocaine (Thomas et al., 2003) . Similar cellular imaging data demonstrated that hippocampal Zif268 expression was also highly correlated with the recall of contextshock, and not CS-shock, associations (Hall et al., 2001) , and the knockdown of Zif268 protein in the hippocampus, through intracranial infusion of Zif268 antisense oligodeoxynucleotides (ASO), was subsequently shown to disrupt the reconsolidation of contextual fear memories (Lee et al., 2004) . Therefore, we investigated whether the drug cue-induced upregulation of Zif268 in the amygdala was functionally required for the reconsolidation of memories elicited by discrete appetitive, drug-associated as well as aversive CSs. Reconsolidation of the CS-drug association was assessed by testing the ability of the drug-associated CS to support the learning of a new instrumental drug-seeking response, since this depends specifically on its conditioned reinforcing properties (Di Ciano and Everitt, 2004). We also tested the requirement for Zif268 in the amygdala in the reconsolidation of CS-shock associations in a conditioned freezing procedure (Hall et al., 2001; Nader et al., 2000) .
Results
The acquisition of a new response with conditioned reinforcement procedure used here is similar to that previously described (Di Ciano and Everitt, 2004). Rats were implanted with an intravenous (i.v.) catheter, and with chronic indwelling guide cannulae positioned bilaterally in the BLA (Figure 1) . Following recovery from surgery, all rats underwent 9 days of cocaine selfadministration training (nosepoke responding), during which each self-administered cocaine infusion was paired with a 20 s light CS. The conditioned reinforcing properties of the CS were tested subsequently by measuring its ability to support the acquisition of the new instrumental drug-seeking response of lever pressing in the absence of the primary drug reinforcer (Di Ciano and Everitt, 2004) . Between the training and test stages, the rats were exposed to a brief 15 min session in which a nosepoke resulted in presentation of the CS, but an infusion of saline instead of cocaine. Pilot studies confirmed that this session was sufficient to reactivate the previously formed CS-drug association and render it sensitive to disruption. Thus, the infusion of anisomycin (62.5 g/0.5 l/side) into the BLA immediately after reactivation subsequently impaired the acquisition of the new response ( Figure 
Disruption of CS-Cocaine Memory
Reconsolidation by Intra-BLA Zif268 ASO Zif268 ASO infusion into the BLA resulted in a marked, reactivation-dependent impairment in the acquisition of the new instrumental drug-seeking response. The reactivated control MSO group learned to respond on the active lever for the CS over the four sessions of acquisition (1, 2, 5, and 8 days after reactivation), and responding was significantly higher than on the inactive lever ( Figure 2A ). In contrast, the reactivated Zif268 ASOinfused group made many fewer responses on the active lever than control rats and showed no preference for the active lever over the inactive lever for up to 8 days after reactivation. The ASO-induced impairment in the acquisition of a new response was critically dependent upon reactivation of the CS-drug memory, since rats that were infused with Zif268 ASO, but with the memory reactivation session omitted, readily learned the new instrumental response with conditioned reinforcement. Both Zif268 ASO-and MSO-infused rats in the nonreactivated condition thus showed strong preference for the active lever over the inactive lever ( Figure  2B ). An overall comparison of reactivated and nonreactivated groups revealed a reactivation-dependent effect of ASO infusion upon lever preference at the third and fourth test sessions, which indicates a persistent failure to learn the new response. Indeed, repeated testing of a subgroup of Zif268 ASO-infused rats revealed a complete failure to learn the new instrumental response up to 27 days after reactivation ( Figure 2C ). Given that reactivation dependence is an important criterion for the reconsolidation process (Lewis, 1979) , the present results demonstrate that CS-drug associations undergo reconsolidation and that Zif268 ASO infusion into the BLA impairs this reconsolidation process.
Importantly, there was no difference between the groups in overall (inactive and active) lever-pressing activity or nosepoke responses during the test sessions ( Figure S2 ), which reveals that there was no deficit in general motivation or activity. Furthermore, the reactivation dependence of the impairment demonstrates that Zif268 ASO had no nonspecific effects on leverpressing performance. Prior to the conditioned reinforcement test, all groups acquired to the same degree the nosepoke response under a fixed-ratio 1 (FR1) schedule for i.v. cocaine reinforcement (data not shown; all ps > 0.28), and the total number of CS-drug pairings was similar across all groups (data not shown; ASO × reactivation; F < 1). Importantly, therefore, conditioning of the CS-drug association was equivalent in all groups. Finally, during the reactivation session the ASO and MSO groups performed similar numbers of nosepoke responses ( Figure 2D ) and consequently received similar numbers of nonreinforced CS exposures ( Figure  2E) . Therefore, the ASO-induced impairment in the acquisition of a new response cannot be attributed to prior differences in conditioning, CS exposure or extinction.
Disruption of CS-Fear Memory Reconsolidation
by Intra-BLA Zif268 ASO Following completion of the acquisition of a new response testing, and in order to establish whether aversive as well as appetitive CS memories are dependent upon Zif268 in the amygdala, the same animals were fear conditioned to an auditory CS (see Experimental Procedures). On the following day, the rats were again infused into the BLA with Zif268 ASO or MSO (rats were allocated to experimental groups at random and independently from the acquisition of a new response study), 90 min prior to a brief presentation of the CS to reactivate the CS-footshock association (and to test long-term memory [LTM] for the association). While there was no effect of the ASO infusions on freezing 3 hr after reactivation (i.e., postreactivation short-term memory [PR-STM] was unaffected), ASO infusion resulted in a severe reactivation-dependent impairment in conditioned freezing to the CS both 24 hr (postreactivation long-term memory [PR-LTM]) and 7 days (PR-LTM2) after reactivation ( Figure 3A) . Rats that were infused with Zif268 ASO, but not reactivated, were not impaired at any test ( Figure 3B ). The stable reconsolidation deficit, with intact STM but impaired LTM after reactivation, was not related to any difference in conditioning (freezing at the initial LTM test was the same).
Intra-BLA Zif268 ASO Knocks Down Zif268 Protein
In order to demonstrate that Zif268 ASO infusion does indeed reduce Zif268 protein levels in the BLA, we fearconditioned six rats and infused them with Zif268 ASO or MSO 90 min prior to fear memory reactivation (LTM test). The rats were then killed, and the BLA was microdissected, 2 hr after reactivation, a time point at which we have shown previously that Zif268 protein is elevated (Lee et al., 2004) . Western blot analysis of BLA Zif268 protein levels (Lee et al., 2004) revealed a 65% reduction in ASO-infused rats, relative to MSO-infused controls ( Figure 3C ). Therefore intra-BLA Zif268 ASO infusion knocks down Zif268 protein in the BLA, consistent with previous results using the same ASO sequence (Malkani et al., 2004) .
Discussion
The present results demonstrate that addictive drug memories undergo reconsolidation in a manner similar to fear memories. Specifically, we have demonstrated amnesia for a well-trained and fully consolidated appetitively conditioned CS-drug association. A single reac- , 2000) , the acquisition of a new response with conditioned reinforcement procedure provides an optimal method with which to assess the impact that drug cues will have on relapse to drug seeking.
The instrumental response acquired with conditioned reinforcement models the learning of flexible drugseeking strategies that typify addictive behavior in humans. It has been shown previously to be persistent despite the absence of further pairings of the CS with drug and, once established, to be unaffected by repeated unreinforced exposure to the CS (Di Ciano and Everitt, 2004). The present experiment used few CS exposures during memory reactivation. Therefore, the subsequent persistent deficit in learning with conditioned reinforcement up to at least day 27 is unlikely to reflect the potentiation of any extinction that may have accrued during CS exposure, especially given that rats exposed much more extensively to the CS in the absence of the US prior to learning the new response do show discriminated responding by day 10 (Di Ciano and Everitt, 2004). However, further studies are required to determine conclusively that the impairment in conditioned reinforcement truly reflects a disruption of reconsolidation rather than a potentiation of extinction. For example, varying the degree of CS exposure during reactivation might reveal differential effects of Zif268 ASO. However, studies of fear conditioning have observed reconsolidation deficits using reinforced reactivation procedures that cannot result in extinction (Duvarci and Nader, 2004; Eisenberg and Dudai, 2004). Nevertheless, the disruption of learning with conditioned reinforcement observed here demonstrates that the impact of drug cues on drug seeking can be greatly and persistently reduced by Zif268 knockdown in the amygdala during memory reactivation, regardless of the precise mechanism underlying the behavioral impairment.
Antisense oligodeoxynucleotide infusion tests the requirement for a particular gene product, and the Zif268 ASO sequence used here has previously been infused into both the hippocampus and amygdala ( ., 2003) . It is also possible that Zif268 ASO diffused into overlying portions of the caudate putamen in some, but not all, of the rats. Although such a partial and inconsistent spread into the caudate putamen is unlikely to be the primary cause of the consistent deficit in the acquisition of a new response, the caudal aspect of the caudate putamen has been implicated in learning about safety signals (Rogan et al., 2005) , and so we cannot completely exclude the involvement of extraamygdala areas in the behavioral deficits. However, the reconsolidation impairment observed here, which is reflected in a loss of conditioned reinforcing properties of a cocaine-associated CS, is most likely the result of the knockdown of Zif268 protein in the BLA.
Hippocampal Zif268 is necessary for the reconsolida- , 2002) . Therefore, the ability to disrupt retroactively the conditioned reinforcing properties of a drug cue provides a potentially powerful and novel approach to the treatment of drug addiction by diminishing the behavioral impact of drug cues and thereby relapse. Furthermore, given that the cellular processes underlying reconsolidation are doubly dissociable from those underlying consolidation, at least in the hippocampus (Lee et al., 2004) , it is possible to manipulate preexisting maladaptive memories in a highly specific manner, without affecting either the reconsolidation of other established memories, or the consolidation of new memories.
In conclusion, the present data confirm that the synthesis of proteins is necessary for the reconsolidation of CS-addictive drug memories, identify the specific requirement of the gene Zif268 in this reconsolidation process, and also demonstrate a commonality in the molecular mechanisms supporting aversive and appetitive memory reconsolidation.
Experimental Procedures Subjects
The subjects used were 82 adult male Lister hooded rats (Charles River, UK), ranging from 275 g to 325 g in weight. They were housed in pairs prior to surgery, and singly thereafter, in holding rooms maintained at 21°C on a reversed light cycle (12 hr light:12 hr dark; lights on at 19:00). During the procedure for acquisition of a new response, food was restricted to 20 g/day. Water was freely available throughout the experiment. All procedures were conducted in accordance with the United Kingdom 1986 Animals (Scientific Procedures) Act (Project License PPL 80/1767).
Surgery and Histology
Rats were implanted with a single catheter in the right jugular vein, and also with bilateral chronic indwelling guide cannulae targeting the BLA. The coordinates for cannulae implantation were (relative to bregma) as follows: AP −2.6; ML ±4.5; DV −5.6 (from dura). Details of the i.v. and stereotaxic surgical procedures are described elsewhere (Di Ciano and Everitt, 2001). A minimum of 7 days was allowed before behavioral training and testing began. At the end of the experiment, the rats were perfused, and their brains were cut to produce 60 m coronal sections, which were stained with cresyl violet. Assessment under light microscopy revealed accurate cannula placements in 52 of the rats.
Infusions
Infusions were carried out using a syringe pump, connected to injectors (28 gauge, projecting 2 mm beyond the guide cannulae) by polyethylene tubing. Infusions of anisomycin (62.5 g/0.5 l/side) or sterile PBS vehicle (0.5 l/side) were begun immediately after insertion of the injectors and were carried out over 90 s. One minute waiting time after completion of the infusion was allowed for diffusion away from the injector tips before the injectors were withdrawn. Oligodeoxynucleotides (1.0 l/side; 0.125 l/min) were PAGE-purified phosphorothioate end-capped 18-mer sequences, resuspended in sterile PBS to a concentration of 2 nmol/µl as used previously (Lee et al., 2004) : Zif268 ASO, 5#-GGTAGTTGTCCATG GTGG-3#; Zif268 MSO, 5#-GTGTTCGGTAGGGTGTCA-3#. A biotinylated Zif268 MSO was infused unilaterally into the BLA to visualize the spread of the MSO both 90 min and 24 hr after infusion.
SDS-PAGE and Western Blotting
Following CS fear reactivation, rats were killed by carbon dioxide inhalation. The rats were decapitated, and their brains were rapidly removed and placed on ice. The BLA was microdissected and frozen on dry ice prior to storage at −80°C. Tissue lysates and Western blotting were performed essentially as previously described (Lee et al., 2004; Ying et al., 2002) . Proteins were separated on 7.5% Tris-HCl gels at a constant voltage of 80 V and then transferred to nitrocellulose membranes at a constant voltage of 100 V for 1 hr. Blots were blocked in 5% nonfat milk in 0.01 M Tris-buffered saline solution containing 0.05% Tween 20 (TBST), and this TBST solution was used for all subsequent incubations and washes. Primary and secondary antibodies were used at the following concentrations: Zif268 (kind gift G.I. Evan, University of California, San Francisco), 1:10,000; β-actin (loading control), 1:20,000; goat antirabbit and goat anti-mouse IgG (whole-molecule)-peroxidase conjugates, 1:1,000. Blots were developed using enhanced chemiluminescence and opposed to autoradiographic film. Autoradiographic images were captured using a Photometrics CoolSnap CCD digital camera and quantified using Openlab software. Autoradiographs of each Western blot were developed to be linear in the range used for densitometry for both Zif268 and β-actin. For analysis, optical density (OD) values and the band areas were obtained for each microdissected BLA sample for both Zif268 and the β-actin loading control, and an OD × area calculation was made to derive an amount figure. Loading variation was corrected by averaging the amount of β-actin across samples on each Western blot and deriving a normalization factor for each sample. Data were analyzed using a one-way ANOVA. To test the acquisition of a new response, two levers were extended into the chamber. A response on the lever located beneath the CS light (inactive lever) had no programmed consequence, whereas a response on the opposite (active) lever was followed by a 1 s illumination of the CS light, during which the house light was extinguished. Nosepoke responses had no programmed consequence, the infusion pump was never activated, and the number of active and inactive lever presses was recorded during the 30 min session. Test sessions were run on 2 consecutive days following reactivation, and then twice more at an interval of 2 days each.
Behavioral Apparatus and Procedures
Fear conditioning took place in four specially configured operant chambers (Paul Fray Ltd., Cambridge, UK), in which the house light and three lights on the front wall were illuminated during conditioning. Rats were habituated to the context overnight and on the next morning were subjected to five CS-shock pairings with an ITI of 5 ± 1 min. The CS was a clicker (60 s, 10 Hz, 80 dB) and was reinforced by a mild footshock (0.5 mA, 0.5 s). In all subsequent sessions for reactivation and testing, rats were returned to the chambers and after 1 min were exposed to the 60 s CS. Behavior was video recorded and subsequently analyzed for freezing, defined as the lack of movement except for breathing, at 5 s intervals to give the percentage time freezing during the CS. 
Statistical Analysis

